CLASS III ONGOING Drug recall · Reported 10 Jun 2026 · FDA Enforcement Report

Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia US

Eugia US is recalling Lidocaine HCl Injection, USP 2%, 40 mg/ (20 mg/mL) per Single-Dose Vial, distributed nationwide in the US. The recall was initiated on 18 May 2026 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
NDC76420-760
Quantity recalled168,300 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0552-2026
FDA event ID
99024
Recalling firm
Eugia US, East Windsor, NJ
Manufacturer
Asclemed USA, Inc.
Classification
Class III
Status
Ongoing
Recall initiated
18 May 2026
FDA classified
29 May 2026
Reported
10 Jun 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

18 May 2026Recall initiated by company
29 May 2026Classified by FDA+11 days
10 Jun 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Product as listed by the FDA

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Where it was distributed

US Nationwide.

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Which lots are affected?

Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029

Where was it sold?

US Nationwide.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Eugia US

All 17

Other Lidocaine recalls

All 120